戻る Agenda
Session 6: Future Developments and Projects on Clinical Trial Regulations
Session Chair(s)
Nick Sykes, MS
Policy Advisor, Regulatory Strategy
EFPIA, Belgium
The conduct and management of clinical trials continues to evolve. A number of initiatives and programmes have been established to ensure the regulatory oversight of clinical trials is aligned with the way clinical trials are being conducted and planned. This session will explore some of the ongoing work from some of the initiatives and will discuss how they will help ensure clinical research can continue to be conducted effectively and efficiently.
Speaker(s)
Developments in ICH
Solange Corriol-Rohou, DrMed, MD, PHD
SCR Consulting, France
What has been done in IMI Project (to support Clinical Development)
Magda Chlebus, MA
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium
Executive Director, Science Policy & Regulatory Affairs
TransCelerate Initiatives to Modernise Clinical Development
Alison Bond, PHD
Amgen, United Kingdom
Director, Global Regulatory and R&D Policy